Loading…

Allogeneic hematopoietic cell transplantation for high-risk CLL: 10-year follow-up of the GCLLSG CLL3X trial

Saved in:

Bibliographic Details
Published in:	Blood 2017-09, Vol.130 (12), p.1477-1480
Main Authors:	Krämer, Isabelle, Stilgenbauer, Stephan, Dietrich, Sascha, Böttcher, Sebastian, Zeis, Matthias, Stadler, Michael, Bittenbring, Jörg, Uharek, Lutz, Scheid, Christof, Hegenbart, Ute, Ho, Anthony, Hallek, Michael, Kneba, Michael, Schmitz, Norbert, Döhner, Hartmut, Dreger, Peter
Format:	Article
Language:	English
Subjects:	Adult Aged Alemtuzumab - therapeutic use Allografts Antineoplastic Agents, Immunological - therapeutic use Combined Modality Therapy Disease-Free Survival Female Follow-Up Studies Graft vs Host Disease - epidemiology Graft vs Host Disease - etiology Humans Kaplan-Meier Estimate Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy Leukemia, Lymphocytic, Chronic, B-Cell - mortality Leukemia, Lymphocytic, Chronic, B-Cell - pathology Leukemia, Lymphocytic, Chronic, B-Cell - therapy Male Middle Aged Molecular Targeted Therapy Neoplasm, Residual Peripheral Blood Stem Cell Transplantation - statistics & numerical data Prognosis Pyrazoles - therapeutic use Pyrimidines - therapeutic use Salvage Therapy Treatment Outcome
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!